Jianping Zeng

804 total citations
48 papers, 486 citations indexed

About

Jianping Zeng is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Jianping Zeng has authored 48 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 8 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Jianping Zeng's work include Cardiovascular Function and Risk Factors (10 papers), Heart Failure Treatment and Management (9 papers) and Acute Myocardial Infarction Research (8 papers). Jianping Zeng is often cited by papers focused on Cardiovascular Function and Risk Factors (10 papers), Heart Failure Treatment and Management (9 papers) and Acute Myocardial Infarction Research (8 papers). Jianping Zeng collaborates with scholars based in China, Israel and Canada. Jianping Zeng's co-authors include Weiyi Mai, Dongqi An, Yuli Huang, He Huang, Xiaoyan Cai, Weijun Huang, Dingli Xu, Renya Zhan, Yu Zhu and Jianwei Pan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Aquaculture.

In The Last Decade

Jianping Zeng

43 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianping Zeng China 10 197 108 81 68 50 48 486
Ane Cláudia Fernandes Nunes United States 13 174 0.9× 127 1.2× 48 0.6× 33 0.5× 73 1.5× 25 546
James W.S. Jahng United States 10 176 0.9× 263 2.4× 136 1.7× 117 1.7× 68 1.4× 21 626
Steve Martin Canada 11 216 1.1× 99 0.9× 75 0.9× 192 2.8× 63 1.3× 17 634
Longyun Peng China 14 329 1.7× 259 2.4× 32 0.4× 69 1.0× 52 1.0× 32 701
Yaobin Zhu China 11 74 0.4× 147 1.4× 82 1.0× 58 0.9× 98 2.0× 29 405
K. Rajeshwar India 10 100 0.5× 84 0.8× 127 1.6× 44 0.6× 47 0.9× 11 384
José Alberto Navarro‐García Spain 14 165 0.8× 168 1.6× 33 0.4× 69 1.0× 37 0.7× 39 528
Dmitri Belov United States 5 117 0.6× 280 2.6× 91 1.1× 45 0.7× 56 1.1× 8 903
Keiichi Torimoto Japan 14 149 0.8× 163 1.5× 61 0.8× 167 2.5× 29 0.6× 58 777
Zhen-Zhou Zhang China 15 174 0.9× 168 1.6× 50 0.6× 187 2.8× 51 1.0× 18 601

Countries citing papers authored by Jianping Zeng

Since Specialization
Citations

This map shows the geographic impact of Jianping Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Zeng more than expected).

Fields of papers citing papers by Jianping Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianping Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Zeng. The network helps show where Jianping Zeng may publish in the future.

Co-authorship network of co-authors of Jianping Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Jianping Zeng. A scholar is included among the top collaborators of Jianping Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianping Zeng. Jianping Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Peng, Yonggang, Ying Yu, Jianping Zeng, et al.. (2025). Design and synthesis of novel zwitterionic-quaternary ammonium chitosan derivatives of distinct categories: Strategies for enhancing antibacterial, antioxidant, and biocompatible properties. International Journal of Biological Macromolecules. 309(Pt 1). 142665–142665. 4 indexed citations
3.
Peng, Yonggang, Ying Yu, Jianping Zeng, et al.. (2025). Regulatory effects of different spacer alkyl chains on the in vitro antioxidant and antibacterial activities of chitosan quaternary ammonium/phosphonium salt derivatives. International Journal of Biological Macromolecules. 307(Pt 3). 142098–142098. 4 indexed citations
4.
Zhou, Xianghong Jasmine, et al.. (2024). Long-term impact of air pollution on heart failure readmission in unstable angina patients. Scientific Reports. 14(1). 22132–22132. 2 indexed citations
5.
Zeng, Jianping, et al.. (2024). Sex-specific impact of mild obesity on the prognosis of ST-segment elevation myocardial infarction. Scientific Reports. 14(1). 2228–2228. 1 indexed citations
6.
Zhang, Lingling, et al.. (2024). Impact of chest pain center quality control indicators on mortality risk in ST-segment elevation myocardial infarction patients: a study based on Killip classification. Frontiers in Cardiovascular Medicine. 10. 1243436–1243436. 1 indexed citations
7.
Zeng, Jianping, et al.. (2024). Long-term effects of air quality on hospital readmission for heart failure in patients with acute myocardial infarction. International Journal of Cardiology. 412. 132344–132344.
8.
Zhang, Hui, Yuying Zhou, Mingxin Wu, et al.. (2023). Prognostic impact of lung ultrasound detected B-lines on hospitalised ischaemic heart failure with mildly reduced ejection fraction patients. Open Heart. 10(2). e002480–e002480. 1 indexed citations
9.
Huang, Haobo, Ke Peng, Sihao Chen, et al.. (2023). Red blood cell count and risk of adverse outcomes in patients with mildly reduced left ventricular ejection fraction. Clinical Cardiology. 46(10). 1276–1284. 4 indexed citations
10.
Wu, Chao, Jianping Zeng, Haiyan Xu, et al.. (2023). Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry. BMC Cardiovascular Disorders. 23(1). 103–103. 3 indexed citations
11.
Chen, Yongliang, Haobo Huang, Lingling Zhang, et al.. (2023). Impact of Atrial Fibrillation on Cerebro-Cardiovascular Outcome of Heart Failure with Mildly-Reduced Ejection Fraction. ESC Heart Failure. 10(5). 2882–2894. 1 indexed citations
12.
Wu, Mingxin, Haobo Huang, Yongliang Chen, et al.. (2022). Risk Factors of Short-Term, Intermediate-Term, and Long-Term Cardiac Events in Patients Hospitalized for HFmrEF. ESC Heart Failure. 9(5). 3124–3138. 6 indexed citations
13.
Yuan, Guangxiong, Xia Hong, Jun Xu, et al.. (2022). Reducing intravenous thrombolysis delay in acute ischemic stroke through a quality improvement program in the emergency department. Frontiers in Neurology. 13. 931193–931193. 8 indexed citations
14.
Wu, Mingxin, Haobo Huang, Ke Peng, et al.. (2022). Obesity increases cardiovascular mortality in patients with HFmrEF. Frontiers in Cardiovascular Medicine. 9. 967780–967780. 3 indexed citations
15.
Zeng, Jianping, et al.. (2022). Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma. Frontiers in Genetics. 13. 928407–928407. 3 indexed citations
16.
Zeng, Jianping, et al.. (2021). Clinical value of pulmonary congestion detection by lung ultrasound in patients with chronic heart failure. Clinical Cardiology. 44(11). 1488–1496. 8 indexed citations
17.
Tai, Shi, Jiaxing Sun, Yuying Zhou, et al.. (2021). Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux. Journal of Advanced Research. 41. 205–218. 49 indexed citations
18.
19.
Huang, Yuli, Weijun Huang, Weiyi Mai, et al.. (2017). White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. Journal of Hypertension. 35(4). 677–688. 128 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ane Cláudia Fernandes Nunes Breakdown of academic impact, for papers by James W.S. Jahng Breakdown of academic impact, for papers by Steve Martin Breakdown of academic impact, for papers by Longyun Peng Breakdown of academic impact, for papers by Yaobin Zhu Breakdown of academic impact, for papers by K. Rajeshwar Breakdown of academic impact, for papers by José Alberto Navarro‐García Breakdown of academic impact, for papers by Dmitri Belov Breakdown of academic impact, for papers by Keiichi Torimoto Breakdown of academic impact, for papers by Zhen-Zhou Zhang
Rankless by CCL
2026